Although the pathogenesis of gastrointestinal symptoms in patients with COVID-19 remains unclear, it may be related to the recruitment of inflammatory cells into the gastrointestinal tract, which releases inflammatory factors, and the expression of angiotensin-converting enzyme 2 in the gastrointestinal tract25. This evidence concerns the gene ACE2 and COVID-19.